Decreased arterial oxygenation during sodium nitoprusside administration for intraoperative hypertension.
D000769:Anesthesia, Inhalation / Q000009:adverse effects*; D000771:Anesthesia, Intravenous / Q000009:adverse effects*; D005292:Ferricyanides / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D009020:Morphine / Q000009:adverse effects; D009599:Nitroprusside / Q000627:therapeutic use*; D009609:Nitrous Oxide / Q000009:adverse effects*; D010100:Oxygen / Q000097:blood*; D013514:Surgical Procedures, Operative / Q000009:adverse effects*
D005292:Ferricyanides; D009599:Nitroprusside; D009020:Morphine; D009609:Nitrous Oxide; D010100:Oxygen